Natural infection or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confer considerable protection against reinfection and reduce the
Continue reading »
Home »
Antibodies produced by SARS-CoV-2 variants vary in ability to neutralise other variants of the virus
Researchers at the Francis Crick Institute and University College London Hospitals NHS Foundation Trust (UCLH) have studied whether antibodies produced
Continue reading »
Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine
Researchers in the United States have provided important insights into the antigen-specific cellular response and evolving humoral (antibody) response to
Continue reading »
Unraveling the mysterious mutations that make delta the most transmissible covid virus yet
Upon first inspection, the mutations in the highly contagious delta covid variant don't look that worrisome. For starters, delta has
Continue reading »
The potential of mRNA vaccines for a wide range of diseases
Vaccination is an important strategy to prevent the transmission of various infectious diseases such as rubella, smallpox, measles, mumps, and
Continue reading »
New imaging technique helps reveal the best antibodies for COVID-19 detection
Vaccines are turning the tide of the pandemic, but the risk of infection is still present in some situations. If
Continue reading »
Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)
The monoclonal antibodies identified target the S2 subunit of the virus spike protein and inhibit viral infection by preventing membrane
Continue reading »
Scientists unveil new Ebola virus vaccine design
Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard
Continue reading »
UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas
UT Southwestern Medical Center scientists have identified the first cases of the Brazilian variant of COVID-19 infection in North Texas
Continue reading »
Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection
By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »